Literature DB >> 15324903

Discovery of potent and selective beta-homophenylalanine based dipeptidyl peptidase IV inhibitors.

Jinyou Xu1, Hyun O Ok, Edward J Gonzalez, Lawrence F Colwell, Bahanu Habulihaz, Huaibing He, Barbara Leiting, Kathryn A Lyons, Frank Marsilio, Reshma A Patel, Joseph K Wu, Nancy A Thornberry, Ann E Weber, Emma R Parmee.   

Abstract

Modification of in-house screening lead beta-aminoacyl proline 8 gave an equipotent thiazolidide 9. Extensive SAR studies on the phenyl ring of 9 led to the discovery of a novel series of potent and selective DP-IV inhibitors. Introduction of a fluorine at the 2-position proved to be crucial for the potency of this series. The 2,5-difluoro (22q) and 2,4,5-trifluoro (22t) analogues were potent inhibitors of DP-IV (IC(50)=270, 119nM, respectively).

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15324903     DOI: 10.1016/j.bmcl.2004.06.099

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  5 in total

Review 1.  The pharmacological landscape and therapeutic potential of serine hydrolases.

Authors:  Daniel A Bachovchin; Benjamin F Cravatt
Journal:  Nat Rev Drug Discov       Date:  2012-01-03       Impact factor: 84.694

2.  3D-QSAR studies of Dipeptidyl peptidase IV inhibitors using a docking based alignment.

Authors:  Raghuvir R S Pissurlenkar; Mushtaque S Shaikh; Evans C Coutinho
Journal:  J Mol Model       Date:  2007-08-04       Impact factor: 1.810

3.  Molecular docking and 3D-QSAR studies on beta-phenylalanine derivatives as dipeptidyl peptidase IV inhibitors.

Authors:  Yan-Ke Jiang
Journal:  J Mol Model       Date:  2010-01-13       Impact factor: 1.810

4.  Two methods for the preparation of sitagliptin phosphate via chemical resolution and asymmetric hydrogenation.

Authors:  Fei Ye; Zhifeng Zhang; Wenxia Zhao; Jianhai Ding; Yali Wang; Xueyan Dang
Journal:  RSC Adv       Date:  2021-01-25       Impact factor: 3.361

5.  Navigating the chemical space of dipeptidyl peptidase-4 inhibitors.

Authors:  Watshara Shoombuatong; Veda Prachayasittikul; Nuttapat Anuwongcharoen; Napat Songtawee; Teerawat Monnor; Supaluk Prachayasittikul; Virapong Prachayasittikul; Chanin Nantasenamat
Journal:  Drug Des Devel Ther       Date:  2015-08-10       Impact factor: 4.162

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.